Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMab.
Zhao L, Xie F, Tong X, Li H, Chen Y, Qian W, Duan S, Zheng J, Zhao Z, Li B, Zhang D, Zhao J, Dai J, Wang H, Hou S, Guo Y.
Zhao L, et al. Among authors: zhao z, zhao j.
MAbs. 2014 May-Jun;6(3):740-8. doi: 10.4161/mabs.28613. Epub 2014 Mar 26.
MAbs. 2014.
PMID: 24670986
Free PMC article.